Introduction: The evolving landscape of surgical interventions for early-stage non-small cell lung cancer (NSCLC) necessitates a reassessment of the traditional gold standard of lobectomy versus emerging sublobar resections, prompting this critical narrative review. Areas covered: This review encompasses recent randomized controlled trials, notably JCOG0802/WJOG4607L and CALGB140503, comparing lobectomy and sublobar resections for early-stage NSCLC, focusing on tumor size and recurrence rates. It also discusses the importance of individualized decision-making, future research avenues, and technological advancements in lung cancer surgery. Expert opinion: In this rapidly evolving field, sublobar resections emerge as a viable alternative to lobectomy for tumors smaller than 2 cm in early-stage NSCLC, necessitating precise patient selection and ongoing technological advancements to optimize outcomes.
Advances in lung cancer surgery: the role of segmentectomy in early–stage management / L. Bertolaccini, M. Casiraghi, C. Uslenghi, C. Diotti, A. Mazzella, G. Caffarena, L. Spaggiari. - In: EXPERT REVIEW OF RESPIRATORY MEDICINE. - ISSN 1747-6348. - 18:9(2024 Sep), pp. 669-675. [10.1080/17476348.2024.2324083]
Advances in lung cancer surgery: the role of segmentectomy in early–stage management
M. CasiraghiSecondo
;C. Uslenghi;C. Diotti;G. CaffarenaPenultimo
;L. SpaggiariUltimo
2024
Abstract
Introduction: The evolving landscape of surgical interventions for early-stage non-small cell lung cancer (NSCLC) necessitates a reassessment of the traditional gold standard of lobectomy versus emerging sublobar resections, prompting this critical narrative review. Areas covered: This review encompasses recent randomized controlled trials, notably JCOG0802/WJOG4607L and CALGB140503, comparing lobectomy and sublobar resections for early-stage NSCLC, focusing on tumor size and recurrence rates. It also discusses the importance of individualized decision-making, future research avenues, and technological advancements in lung cancer surgery. Expert opinion: In this rapidly evolving field, sublobar resections emerge as a viable alternative to lobectomy for tumors smaller than 2 cm in early-stage NSCLC, necessitating precise patient selection and ongoing technological advancements to optimize outcomes.File | Dimensione | Formato | |
---|---|---|---|
Expert Rev Respir Med 2024.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
633.55 kB
Formato
Adobe PDF
|
633.55 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.